FDA, Gluck and COVID-19 Testing Device

Gluck Equine Research Center staffer Dr. Ted Kalbfleisch assisted the FDA in approvals for a COVID-19 testing device.

Gluck Equine Research Center staffer Dr. Ted Kalbfleisch assisted the FDA in approvals for a COVID-19 testing device. iStock/Flippo Bacci

MatMaCorp in Lincoln, Nebraska, developed a PCR device that was designed for veterinarians to run real-time assays in the field. This self-contained device, which weighs 6 pounds and is the size of a laptop, can produce results within one to two hours.

It was quickly realized that this technology could play a vital role in the fight against COVID-19.

Ted Kalbfleisch, PhD, associate professor at the University of Kentucky Gluck Equine Research Center, was a part of the collaborating team that led to the MatMaCorp device receiving emergency FDA approval for COVID-19 testing. This new COVID assay has now been approved for use in CLIA-approved laboratories; future work would be focused on a device that can be utilized point of care, or in-the-field testing.

“Being a part of a collaboration of this scale with researchers and resources like those at MatMaCorp and the University of Kentucky CCTS, on a project this impactful, is both incredibly exciting and rewarding,” Kalbfleisch said.

Danielle Jostes, Equine Philanthropy Director of the University of Kentucky Ag Equine Programs, provided this information.

equimanagement signup

Partners

aaep media partner
avma plit
weva logo
nzeva logo
iselp logo
aaevt logo
naep logo
epm society partner logo
mexican equine vet association logo